Clinical Trial Update: Efficacy and Safety on Prouk for STEMI Patients in China [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update reports on the efficacy and safety of Prouk in patients with ST-elevation myocardial infarction (STEMI) in China.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Drugs mentioned

• Prouk

Snippet

Sponsor: Suzhou RxD Biopharmaceutical Co., Ltd | Conditions: STEMI | Phase 3 | Status: UNKNOWN